Roche Drug to Raise 'Good' Cholesterol Fails - WSJ
PDF) Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
Roche Abandons Dalcetrapib Trial
Solubility and stability of dalcetrapib in vehicles and biological media - ScienceDirect
Dalcetrapib (JTT-705) | CETP Inhibitor | MedChemExpress
PDF) Safety and Tolerability of Dalcetrapib | Brendan Buckley and David Kallend - Academia.edu
Cholesteryl ester transfer-protein modulator and inhibitors and their potential for the treatment of cardiovascular diseases. - Abstract - Europe PMC
PDF) Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans
PDF) Dalcetrapib preserves CETP-induced pre-β-HDL formation in vitro, in contrast to torcetrapib and anacetrapib | Evelyne Chaput - Academia.edu
Safety, Tolerability and Pharmacokinetics of Dalcetrapib Following Single and Multiple Ascending Doses in Healthy Subjects | Clinical Drug Investigation
Dalcetrapib
PDF) Cholesteryl ester transfer protein inhibitors for dyslipidemia: Focus on dalcetrapib
Pharma – Roche stoppe un médicament, le titre dévisse | 24 heures
Roche Sees Big Potential in New Drugs - WSJ
Dalcetrapib - an overview | ScienceDirect Topics
Clinical Pharmacokinetics and Pharmacodynamics of Dalcetrapib | Clinical Pharmacokinetics
Roche Abandons Dalcetrapib Trial
Roche to Develop Companion Diagnostic Test for Dalcetrapi - Elets eHealth
PDF) Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib | Robert Hegele - Academia.edu
Cholesterol Ester Transfer Protein Inhibitor - an overview | ScienceDirect Topics
Molecular structure of Dalcetrapib. Chemical structure of Dalcetrapib... | Download Scientific Diagram
PDF) Safety and Tolerability of Dalcetrapib | Brendan Buckley and David Kallend - Academia.edu
Dalcetrapib (JTT-705) | 99.73%(HPLC) | In Stock | CETP inhibitor
Roche Abandons Dalcetrapib Trial
Dalcetrapib
Roche Abandons Dalcetrapib Trial
PDF) Dalcetrapib: no off-target toxicity on blood pressure or on genes related to the renin-angiotensin-aldosterone system in rats | Eric Niesor - Academia.edu
62032-x.fp.png "STATIN–INDUCED DECREASE IN ABCA1 EXPRESSION VIA MIR33 INDUCTION MAY COUNTERACT CHOLESTEROL EFFLUX BY HIGH–DENSITY LIPOPROTEINS RAISED WITH THE CHOLESTERYL ESTER TRANSFER PROTEIN MODULATOR DALCETRAPIB | Journal of the American College of Cardiology")